Joshua Jennings
Stock Analyst at TD Cowen
(2.68)
# 1,941
Out of 5,112 analysts
75
Total ratings
48.57%
Success rate
4.49%
Average return
Main Sectors:
Stocks Rated by Joshua Jennings
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OBIO Orchestra BioMed Holdings | Initiates: Buy | $15 | $4.46 | +236.32% | 1 | Dec 10, 2025 | |
| CBLL CeriBell | Maintains: Buy | $36 → $20 | $21.99 | -9.05% | 3 | Nov 5, 2025 | |
| SENS Senseonics Holdings | Maintains: Buy | $25 → $15 | $6.62 | +126.59% | 2 | Nov 5, 2025 | |
| PRCT PROCEPT BioRobotics | Maintains: Buy | $85 → $50 | $35.66 | +40.21% | 4 | Nov 5, 2025 | |
| DXCM DexCom | Maintains: Buy | $100 → $84 | $66.37 | +26.56% | 2 | Oct 31, 2025 | |
| HUMA Humacyte | Maintains: Buy | $5 → $3.5 | $1.12 | +212.50% | 3 | Aug 12, 2025 | |
| AVR Anteris Technologies Global | Initiates: Buy | $15 | $4.95 | +203.03% | 1 | Jan 7, 2025 | |
| PODD Insulet | Maintains: Buy | $264 → $324 | $288.73 | +12.22% | 1 | Jan 3, 2025 | |
| BSX Boston Scientific | Maintains: Buy | $100 → $110 | $92.95 | +18.34% | 7 | Dec 12, 2024 | |
| TMDX TransMedics Group | Maintains: Buy | $175 → $120 | $125.04 | -4.03% | 9 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $50 | $1.54 | +3,146.75% | 1 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $143 → $119 | $90.91 | +30.90% | 1 | Sep 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $55 → $60 | $35.50 | +69.01% | 2 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $83 → $80 | $84.54 | -5.37% | 1 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $135 → $45 | $3.92 | +1,047.96% | 3 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $100 → $70 | $85.32 | -17.96% | 1 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $195 → $185 | $209.30 | -11.61% | 1 | Jul 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $40 | $19.05 | +109.97% | 4 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $365 → $400 | $351.69 | +13.74% | 2 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $50 → $60 | $74.15 | -19.08% | 4 | Mar 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $52 → $34 | $22.60 | +50.44% | 2 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $14 → $18 | $7.55 | +138.41% | 3 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $6 → $25 | $18.77 | +33.23% | 1 | Dec 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $130 | $126.86 | +2.48% | 9 | Dec 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $7 → $5 | $2.38 | +110.08% | 1 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $125 → $117 | $97.72 | +19.73% | 3 | May 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $450 | $2.43 | +18,418.52% | 1 | Dec 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $12 | $19.76 | -39.27% | 1 | Sep 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $306 → $275 | $196.39 | +40.03% | 1 | Feb 7, 2020 |
Orchestra BioMed Holdings
Dec 10, 2025
Initiates: Buy
Price Target: $15
Current: $4.46
Upside: +236.32%
CeriBell
Nov 5, 2025
Maintains: Buy
Price Target: $36 → $20
Current: $21.99
Upside: -9.05%
Senseonics Holdings
Nov 5, 2025
Maintains: Buy
Price Target: $25 → $15
Current: $6.62
Upside: +126.59%
PROCEPT BioRobotics
Nov 5, 2025
Maintains: Buy
Price Target: $85 → $50
Current: $35.66
Upside: +40.21%
DexCom
Oct 31, 2025
Maintains: Buy
Price Target: $100 → $84
Current: $66.37
Upside: +26.56%
Humacyte
Aug 12, 2025
Maintains: Buy
Price Target: $5 → $3.5
Current: $1.12
Upside: +212.50%
Anteris Technologies Global
Jan 7, 2025
Initiates: Buy
Price Target: $15
Current: $4.95
Upside: +203.03%
Insulet
Jan 3, 2025
Maintains: Buy
Price Target: $264 → $324
Current: $288.73
Upside: +12.22%
Boston Scientific
Dec 12, 2024
Maintains: Buy
Price Target: $100 → $110
Current: $92.95
Upside: +18.34%
TransMedics Group
Nov 18, 2024
Maintains: Buy
Price Target: $175 → $120
Current: $125.04
Upside: -4.03%
Oct 2, 2024
Initiates: Buy
Price Target: $50
Current: $1.54
Upside: +3,146.75%
Sep 6, 2024
Maintains: Hold
Price Target: $143 → $119
Current: $90.91
Upside: +30.90%
Aug 27, 2024
Maintains: Buy
Price Target: $55 → $60
Current: $35.50
Upside: +69.01%
Aug 13, 2024
Maintains: Hold
Price Target: $83 → $80
Current: $84.54
Upside: -5.37%
Aug 8, 2024
Maintains: Buy
Price Target: $135 → $45
Current: $3.92
Upside: +1,047.96%
Jul 25, 2024
Downgrades: Hold
Price Target: $100 → $70
Current: $85.32
Upside: -17.96%
Jul 18, 2024
Maintains: Buy
Price Target: $195 → $185
Current: $209.30
Upside: -11.61%
May 10, 2024
Downgrades: Hold
Price Target: $40
Current: $19.05
Upside: +109.97%
Apr 11, 2024
Maintains: Buy
Price Target: $365 → $400
Current: $351.69
Upside: +13.74%
Mar 12, 2024
Maintains: Outperform
Price Target: $50 → $60
Current: $74.15
Upside: -19.08%
Aug 4, 2023
Maintains: Outperform
Price Target: $52 → $34
Current: $22.60
Upside: +50.44%
May 11, 2023
Maintains: Outperform
Price Target: $14 → $18
Current: $7.55
Upside: +138.41%
Dec 30, 2022
Maintains: Outperform
Price Target: $6 → $25
Current: $18.77
Upside: +33.23%
Dec 13, 2022
Maintains: Outperform
Price Target: $130
Current: $126.86
Upside: +2.48%
Nov 11, 2022
Maintains: Outperform
Price Target: $7 → $5
Current: $2.38
Upside: +110.08%
May 27, 2022
Maintains: Outperform
Price Target: $125 → $117
Current: $97.72
Upside: +19.73%
Dec 7, 2021
Initiates: Outperform
Price Target: $450
Current: $2.43
Upside: +18,418.52%
Sep 3, 2020
Initiates: Outperform
Price Target: $12
Current: $19.76
Upside: -39.27%
Feb 7, 2020
Downgrades: Market Perform
Price Target: $306 → $275
Current: $196.39
Upside: +40.03%